跳至主要内容
临床试验/NCT06238674
NCT06238674进行中(未招募)1 期

Early Goal Nutrition Therapy Guided by Indirect Calorimetry and Nitrogen Balance Among Critically Ill Patients With Acute Kidney Injury

Wankawee Jeerangsapasuk2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年3月7日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80
试验地点
2
主要终点
28 day mortality

研究概览

简要总结

The goal of this clinical trial is to investigate the effects of nutrition therapy guided by indirect calorimetry and nitrogen balance among critically ill patients with acute kidney injury. The main question it aims to answer whether nutrition therapy guided by indirect calorimetry and nitrogen balance could improve 28 days mortality among critically ill patients with acute kidney injury or not.

type of study: clinical trial Participants will be provided enteral or parenteral nutrition after randomization(48-72 days after admissions) with total energy guided by indirect calorimetry measurements and total protein by nitrogen balance with maximum of 1.3 gram per kilogram per day for total of 14 days If there is a comparison group: Researchers will compare with the control groups (nutrition therapy provided by physician using clinical equation of choice or judgements to see if participants were provided with these interventions, their 28 days mortalities would be better

详细描述

The gold standard for determining energy requirements was recommended by the European Society for Parenteral and Enteral Nutrition (ESPEN) guideline 2021 to use indirect calorimetry(IC), a noninvasive method that allows resting energy expenditure (REE) evaluation based on measurements of oxygen consumption and carbon dioxide production in the exhaled air.

As there are no high-quality studies that investigated energy and protein provision in hospitalized patients with acute kidney injury(AKI) or Acute kidney disease (AKD), the recommendations were based on the guidelines and clinical trials from critically ill and polymorbid internal medicine patients because these guidelines and trials included patients with kidney disease.

Moreover, there were clinical trials in critically ill patients with severe acute kidney injury found the varying of metabolic states among these patients categorized by IC measurements and no association between calorie intake and mortality outcome.

Even though the aforementioned researches did not suggest a link between calorie intake and mortality outcome, no studies were able to meet the energy targets set using indirect calorimetry measurements.

This study aims to prove the necessary and benefit of early nutrition therapy after 72 hours of admission with total energy guided by indirect calorimetry measurements aims to meet 70-100% from measurements and total protein guided by urine urea nitrogen balance aims to positive nitrogen balance with maximum of 1.3 gram per kilogram of actual body weight per day for total of 14 days on survival & renal outcomes in critically ill patients with acute kidney injury

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-90 years old
  • Mechanically ventilated patients with acute kidney injury by Kidney Disease Improving Global Outcomes (KDIGO) criteria
  • Expected length of ICU stay more than 72 hours and accept to follow the study protocol

排除标准

  • Underlying chronic kidney disease stage 4 or 5 according to KDIGO staging
  • received renal replacement therapy prior to admission
  • Post cardiothoracic surgery
  • Required fraction of inspired oxygen inspired oxygen fraction (FiO2) more than 0.6
  • Pregnancy
  • BMI below 17 or above 35 kg/m2 or very high risk refeeding syndrome
  • Cirrhosis Child-Pugh score C

结局指标

主要结局

28 day mortality

时间窗: up to 28 days after randomization

28 day mortality

次要结局

  • length of ICU stay(up to 28 days)
  • Rate of new renal replacement therapy(up to 28 days)
  • 60 day mortality(up to 60 days)
  • Peak serum creatinine(up to 28 days)
  • Nosocomial infection(up to 28 days)
  • ICU mortality(up to 28 days)
  • Blood sugar level and amount of insulin usage(up to 28 days)
  • adverse events(up to 28 days)
  • Duration of mechanical ventilation(up to 28 days)
  • Treatment separation in energy adequacy(up to 28 days)

研究者

发起方
Wankawee Jeerangsapasuk
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wankawee Jeerangsapasuk

Clinical nephrology fellow, Principal Investigator, Doctor

Thammasat University

研究点 (2)

Loading locations...

相似试验